PER
Click for more information
1.19% 8.5¢ percheron therapeutics limited

This opinion allows Antisense to prepare trial applications for...

  1. Baremoney
    236 Posts.
    lightbulb Created with Sketch. 59
    clock Created with Sketch.
    09/11/21
    20:45
    Post #: 57440661
    This opinion allows Antisense to prepare trial applications for submission for its potentially pivotal Phase IIb/III clinical trial program for the development of ATL1102 for Duchenne muscular
    ANP Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Dominos looks tasty and tempting, but could be too spicy and even dicey
right-arrow Created with Sketch.
GT1 Green Technology hands the helm to Henry
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
NEWS Drill, drill, drill: 3 explorers with news on Friday – Sun Silver, Aurelia & PNX Metals
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
NEWS MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.001(1.19%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.5¢ 8.5¢ 8.5¢ $2.708K 31.85K

Buyers (Bids)

No. Vol. Price($)
2 77428 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 119843 1
View Market Depth
Last trade - 14.29pm 20/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.